LGALS3BP and breast carcinoma: They found that LGALS3BP secreted by the human metastatic breast cancer cells MDA-MB-231 inhibited monocyte-derived fibrocyte differentiation, and, conversely, galectin-3 promoted monocyte-derived fibrocyte differentiation.